C2 Pharma

Company Drug

C2 Pharma Secures C-DMF Approval for Pilocarpine Nitrate API

Fineline Cube Nov 24, 2023

Ireland-based C2 Pharma has announced the receipt of approval for a C-DMF (drug master file)...

Policy / Regulatory

U.S. Tariffs on Pharmaceuticals and Their Impact on China’s Medical Industry

Company Drug

Sichuan Biokin Launches Phase III Trial for BL-B01D1 in Urothelial Carcinoma

Company Drug

AbbVie’s Rinvoq Approved in EU for Giant Cell Arteritis

Company Drug

Bristol-Myers Squibb’s Opdivo/Yervoy Combo Approved for MSI-H Colorectal Cancer